CD19 and leukemia: When the CD19 CAR NK cells additionally expressed IL15 or IL15-IL15R instead of BFP, the leukemia progression was markedly reduced as seen by luminescence imaging (Figure 7C) and peripheral blood analysis (Figure 7E).